Frontiers in Molecular Biosciences-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=895604, encodeId=5b52895604e7, content=审稿速度:2.0 | 投稿命中率:100.0 | 版面费用:2750.0 偏重的研究方向：肿瘤;表观遗传 经验分享：20200324 提交 20200324 Initial Validation 20200325 Editorial Assignment 20200404 Independent Review 20200421 Interactive Review 20200502 回复问题，re-submit 20200507 Review Finalized 20200507 Final Validation 20200508 Final Decision 20200512 打钱 20200526-28 proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/17/4853d202ade50d0bdf35e3b421ad93b5.jpg, createdBy=05211666592, createdName=杨小雅, createdTime=Fri Oct 30 09:39:51 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899607, encodeId=acb089960eba, content=投稿半个月了，还是editor assignment, 怎么还不送审，大家知道啥情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=The chief editor of bbrc, createdTime=Mon Nov 16 13:23:44 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967629, encodeId=8f9c96e6294d, content=请问纯生信，没有基础实验验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 21 23:34:12 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965712, encodeId=eae6965e12b4, content=生信文章为啥突然问我要原始数据，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/icsxtd8pwFpo8Pxq0EZRrQbNZVO7LicJTJ43Pg6pGhE4WawzWaGPD3q9dxRwjPPM9GHdzzzJNPQW1FRGL90HaGQA/0, createdBy=05f12229743, createdName=废伟伟, createdTime=Fri May 14 22:54:07 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970884, encodeId=4a529e088448, content=朋友们，5月21号投出去，到现在还是initial validation 还没有分配编辑，要等多久啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b13f1619698, createdName=ZF2012ZF, createdTime=Fri Jun 04 15:07:01 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180155, encodeId=796011801550d, content=果断撤稿，不能投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Mon Jan 03 21:04:03 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581287, encodeId=2d8a58128e95, content=审稿速度:1.0 经验分享：这杂志速度惊人，投稿后一个月修回，审稿人一个小修，一个moderate修。修回后一周接收。全程两个月。光速好评。而且修回界面，是审稿人与作者的对话模式。非常新颖。接收以后才能看到审稿人的名字。投稿的时候会建议你从编辑库里选择编辑。投稿，修稿模式非常干净，简洁，新颖。最关键是快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f4d1979640, createdName=毛教授, createdTime=Wed Dec 11 00:00:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958196, encodeId=a29c9581965c, content=Independent review 2个月！！！！发邮件催了一下，石沉大海什么回复都没有！我是真的服了！！！这期刊真乃神刊也！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1f55081875, createdName=飞翔的阿吉, createdTime=Mon Apr 19 02:48:29 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898988, encodeId=9d7e898988be, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：9.18 由Frontiers in immunology转投至此 10.19 interactive reriew activated 11.6 resubmitted manuscript 11.11 review finalized<a href='/topic/show?id=f9e2832202f' target=_blank style='color:#2F92EE;'>#胃癌#</a> 11.12 final validation 11.13 accepted for publication 审稿人和编辑蛮负责的，有误和不足之处指点得比较细致，工作效率还蛮高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=6, topicName=null, topicId=null, topicList=[TopicDto(id=83220, encryptionId=f9e2832202f, topicName=胃癌)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2d15412768, createdName=丐帮首席Scientist, createdTime=Fri Nov 13 18:20:02 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805182, encodeId=31688051823b, content=请问一下，Editorial Assignment一个月多了，一直都在这个状态，是没有找到审稿人吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vp81ML0pFfyNwFwGEx9Pw33qtqCn5M04bic15eUEPrwph5jOCicrTRKvKUX6JT7fiawspFQ85y9bCFrahoBiagwsSw/132, createdBy=faf35236748, createdName=治愈., createdTime=Thu Jul 30 12:05:59 CST 2020, time=2020-07-30, status=1, ipAttribution=)]

2020-10-30 杨小雅

审稿速度:2.0 | 投稿命中率:100.0 | 版面费用:2750.0
偏重的研究方向：肿瘤;表观遗传
经验分享：20200324 提交
20200324 Initial Validation
20200325 Editorial Assignment
20200404 Independent Review
20200421 Interactive Review
20200502 回复问题，re-submit
20200507 Review Finalized
20200507 Final Validation
20200508 Final Decision
20200512 打钱
20200526-28 proof

95 22

展开22条回复

[GetPortalCommentsPageByObjectIdResponse(id=895604, encodeId=5b52895604e7, content=审稿速度:2.0 | 投稿命中率:100.0 | 版面费用:2750.0 偏重的研究方向：肿瘤;表观遗传 经验分享：20200324 提交 20200324 Initial Validation 20200325 Editorial Assignment 20200404 Independent Review 20200421 Interactive Review 20200502 回复问题，re-submit 20200507 Review Finalized 20200507 Final Validation 20200508 Final Decision 20200512 打钱 20200526-28 proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/17/4853d202ade50d0bdf35e3b421ad93b5.jpg, createdBy=05211666592, createdName=杨小雅, createdTime=Fri Oct 30 09:39:51 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899607, encodeId=acb089960eba, content=投稿半个月了，还是editor assignment, 怎么还不送审，大家知道啥情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=The chief editor of bbrc, createdTime=Mon Nov 16 13:23:44 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967629, encodeId=8f9c96e6294d, content=请问纯生信，没有基础实验验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 21 23:34:12 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965712, encodeId=eae6965e12b4, content=生信文章为啥突然问我要原始数据，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/icsxtd8pwFpo8Pxq0EZRrQbNZVO7LicJTJ43Pg6pGhE4WawzWaGPD3q9dxRwjPPM9GHdzzzJNPQW1FRGL90HaGQA/0, createdBy=05f12229743, createdName=废伟伟, createdTime=Fri May 14 22:54:07 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970884, encodeId=4a529e088448, content=朋友们，5月21号投出去，到现在还是initial validation 还没有分配编辑，要等多久啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b13f1619698, createdName=ZF2012ZF, createdTime=Fri Jun 04 15:07:01 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180155, encodeId=796011801550d, content=果断撤稿，不能投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Mon Jan 03 21:04:03 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581287, encodeId=2d8a58128e95, content=审稿速度:1.0 经验分享：这杂志速度惊人，投稿后一个月修回，审稿人一个小修，一个moderate修。修回后一周接收。全程两个月。光速好评。而且修回界面，是审稿人与作者的对话模式。非常新颖。接收以后才能看到审稿人的名字。投稿的时候会建议你从编辑库里选择编辑。投稿，修稿模式非常干净，简洁，新颖。最关键是快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f4d1979640, createdName=毛教授, createdTime=Wed Dec 11 00:00:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958196, encodeId=a29c9581965c, content=Independent review 2个月！！！！发邮件催了一下，石沉大海什么回复都没有！我是真的服了！！！这期刊真乃神刊也！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1f55081875, createdName=飞翔的阿吉, createdTime=Mon Apr 19 02:48:29 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898988, encodeId=9d7e898988be, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：9.18 由Frontiers in immunology转投至此 10.19 interactive reriew activated 11.6 resubmitted manuscript 11.11 review finalized<a href='/topic/show?id=f9e2832202f' target=_blank style='color:#2F92EE;'>#胃癌#</a> 11.12 final validation 11.13 accepted for publication 审稿人和编辑蛮负责的，有误和不足之处指点得比较细致，工作效率还蛮高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=6, topicName=null, topicId=null, topicList=[TopicDto(id=83220, encryptionId=f9e2832202f, topicName=胃癌)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2d15412768, createdName=丐帮首席Scientist, createdTime=Fri Nov 13 18:20:02 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805182, encodeId=31688051823b, content=请问一下，Editorial Assignment一个月多了，一直都在这个状态，是没有找到审稿人吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vp81ML0pFfyNwFwGEx9Pw33qtqCn5M04bic15eUEPrwph5jOCicrTRKvKUX6JT7fiawspFQ85y9bCFrahoBiagwsSw/132, createdBy=faf35236748, createdName=治愈., createdTime=Thu Jul 30 12:05:59 CST 2020, time=2020-07-30, status=1, ipAttribution=)]

2020-11-16 The chief editor of bbrc

投稿半个月了，还是editor assignment, 怎么还不送审，大家知道啥情况吗?

91 19

展开19条回复

[GetPortalCommentsPageByObjectIdResponse(id=895604, encodeId=5b52895604e7, content=审稿速度:2.0 | 投稿命中率:100.0 | 版面费用:2750.0 偏重的研究方向：肿瘤;表观遗传 经验分享：20200324 提交 20200324 Initial Validation 20200325 Editorial Assignment 20200404 Independent Review 20200421 Interactive Review 20200502 回复问题，re-submit 20200507 Review Finalized 20200507 Final Validation 20200508 Final Decision 20200512 打钱 20200526-28 proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/17/4853d202ade50d0bdf35e3b421ad93b5.jpg, createdBy=05211666592, createdName=杨小雅, createdTime=Fri Oct 30 09:39:51 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899607, encodeId=acb089960eba, content=投稿半个月了，还是editor assignment, 怎么还不送审，大家知道啥情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=The chief editor of bbrc, createdTime=Mon Nov 16 13:23:44 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967629, encodeId=8f9c96e6294d, content=请问纯生信，没有基础实验验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 21 23:34:12 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965712, encodeId=eae6965e12b4, content=生信文章为啥突然问我要原始数据，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/icsxtd8pwFpo8Pxq0EZRrQbNZVO7LicJTJ43Pg6pGhE4WawzWaGPD3q9dxRwjPPM9GHdzzzJNPQW1FRGL90HaGQA/0, createdBy=05f12229743, createdName=废伟伟, createdTime=Fri May 14 22:54:07 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970884, encodeId=4a529e088448, content=朋友们，5月21号投出去，到现在还是initial validation 还没有分配编辑，要等多久啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b13f1619698, createdName=ZF2012ZF, createdTime=Fri Jun 04 15:07:01 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180155, encodeId=796011801550d, content=果断撤稿，不能投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Mon Jan 03 21:04:03 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581287, encodeId=2d8a58128e95, content=审稿速度:1.0 经验分享：这杂志速度惊人，投稿后一个月修回，审稿人一个小修，一个moderate修。修回后一周接收。全程两个月。光速好评。而且修回界面，是审稿人与作者的对话模式。非常新颖。接收以后才能看到审稿人的名字。投稿的时候会建议你从编辑库里选择编辑。投稿，修稿模式非常干净，简洁，新颖。最关键是快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f4d1979640, createdName=毛教授, createdTime=Wed Dec 11 00:00:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958196, encodeId=a29c9581965c, content=Independent review 2个月！！！！发邮件催了一下，石沉大海什么回复都没有！我是真的服了！！！这期刊真乃神刊也！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1f55081875, createdName=飞翔的阿吉, createdTime=Mon Apr 19 02:48:29 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898988, encodeId=9d7e898988be, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：9.18 由Frontiers in immunology转投至此 10.19 interactive reriew activated 11.6 resubmitted manuscript 11.11 review finalized<a href='/topic/show?id=f9e2832202f' target=_blank style='color:#2F92EE;'>#胃癌#</a> 11.12 final validation 11.13 accepted for publication 审稿人和编辑蛮负责的，有误和不足之处指点得比较细致，工作效率还蛮高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=6, topicName=null, topicId=null, topicList=[TopicDto(id=83220, encryptionId=f9e2832202f, topicName=胃癌)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2d15412768, createdName=丐帮首席Scientist, createdTime=Fri Nov 13 18:20:02 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805182, encodeId=31688051823b, content=请问一下，Editorial Assignment一个月多了，一直都在这个状态，是没有找到审稿人吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vp81ML0pFfyNwFwGEx9Pw33qtqCn5M04bic15eUEPrwph5jOCicrTRKvKUX6JT7fiawspFQ85y9bCFrahoBiagwsSw/132, createdBy=faf35236748, createdName=治愈., createdTime=Thu Jul 30 12:05:59 CST 2020, time=2020-07-30, status=1, ipAttribution=)]

2021-05-21 ms1000000930252947

请问纯生信，没有基础实验验证可以投吗

66 16

展开16条回复

[GetPortalCommentsPageByObjectIdResponse(id=895604, encodeId=5b52895604e7, content=审稿速度:2.0 | 投稿命中率:100.0 | 版面费用:2750.0 偏重的研究方向：肿瘤;表观遗传 经验分享：20200324 提交 20200324 Initial Validation 20200325 Editorial Assignment 20200404 Independent Review 20200421 Interactive Review 20200502 回复问题，re-submit 20200507 Review Finalized 20200507 Final Validation 20200508 Final Decision 20200512 打钱 20200526-28 proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/17/4853d202ade50d0bdf35e3b421ad93b5.jpg, createdBy=05211666592, createdName=杨小雅, createdTime=Fri Oct 30 09:39:51 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899607, encodeId=acb089960eba, content=投稿半个月了，还是editor assignment, 怎么还不送审，大家知道啥情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=The chief editor of bbrc, createdTime=Mon Nov 16 13:23:44 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967629, encodeId=8f9c96e6294d, content=请问纯生信，没有基础实验验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 21 23:34:12 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965712, encodeId=eae6965e12b4, content=生信文章为啥突然问我要原始数据，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/icsxtd8pwFpo8Pxq0EZRrQbNZVO7LicJTJ43Pg6pGhE4WawzWaGPD3q9dxRwjPPM9GHdzzzJNPQW1FRGL90HaGQA/0, createdBy=05f12229743, createdName=废伟伟, createdTime=Fri May 14 22:54:07 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970884, encodeId=4a529e088448, content=朋友们，5月21号投出去，到现在还是initial validation 还没有分配编辑，要等多久啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b13f1619698, createdName=ZF2012ZF, createdTime=Fri Jun 04 15:07:01 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180155, encodeId=796011801550d, content=果断撤稿，不能投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Mon Jan 03 21:04:03 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581287, encodeId=2d8a58128e95, content=审稿速度:1.0 经验分享：这杂志速度惊人，投稿后一个月修回，审稿人一个小修，一个moderate修。修回后一周接收。全程两个月。光速好评。而且修回界面，是审稿人与作者的对话模式。非常新颖。接收以后才能看到审稿人的名字。投稿的时候会建议你从编辑库里选择编辑。投稿，修稿模式非常干净，简洁，新颖。最关键是快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f4d1979640, createdName=毛教授, createdTime=Wed Dec 11 00:00:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958196, encodeId=a29c9581965c, content=Independent review 2个月！！！！发邮件催了一下，石沉大海什么回复都没有！我是真的服了！！！这期刊真乃神刊也！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1f55081875, createdName=飞翔的阿吉, createdTime=Mon Apr 19 02:48:29 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898988, encodeId=9d7e898988be, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：9.18 由Frontiers in immunology转投至此 10.19 interactive reriew activated 11.6 resubmitted manuscript 11.11 review finalized<a href='/topic/show?id=f9e2832202f' target=_blank style='color:#2F92EE;'>#胃癌#</a> 11.12 final validation 11.13 accepted for publication 审稿人和编辑蛮负责的，有误和不足之处指点得比较细致，工作效率还蛮高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=6, topicName=null, topicId=null, topicList=[TopicDto(id=83220, encryptionId=f9e2832202f, topicName=胃癌)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2d15412768, createdName=丐帮首席Scientist, createdTime=Fri Nov 13 18:20:02 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805182, encodeId=31688051823b, content=请问一下，Editorial Assignment一个月多了，一直都在这个状态，是没有找到审稿人吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vp81ML0pFfyNwFwGEx9Pw33qtqCn5M04bic15eUEPrwph5jOCicrTRKvKUX6JT7fiawspFQ85y9bCFrahoBiagwsSw/132, createdBy=faf35236748, createdName=治愈., createdTime=Thu Jul 30 12:05:59 CST 2020, time=2020-07-30, status=1, ipAttribution=)]

2021-05-14 废伟伟

生信文章为啥突然问我要原始数据，

41 16

展开16条回复

[GetPortalCommentsPageByObjectIdResponse(id=895604, encodeId=5b52895604e7, content=审稿速度:2.0 | 投稿命中率:100.0 | 版面费用:2750.0 偏重的研究方向：肿瘤;表观遗传 经验分享：20200324 提交 20200324 Initial Validation 20200325 Editorial Assignment 20200404 Independent Review 20200421 Interactive Review 20200502 回复问题，re-submit 20200507 Review Finalized 20200507 Final Validation 20200508 Final Decision 20200512 打钱 20200526-28 proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/17/4853d202ade50d0bdf35e3b421ad93b5.jpg, createdBy=05211666592, createdName=杨小雅, createdTime=Fri Oct 30 09:39:51 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899607, encodeId=acb089960eba, content=投稿半个月了，还是editor assignment, 怎么还不送审，大家知道啥情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=The chief editor of bbrc, createdTime=Mon Nov 16 13:23:44 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967629, encodeId=8f9c96e6294d, content=请问纯生信，没有基础实验验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 21 23:34:12 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965712, encodeId=eae6965e12b4, content=生信文章为啥突然问我要原始数据，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/icsxtd8pwFpo8Pxq0EZRrQbNZVO7LicJTJ43Pg6pGhE4WawzWaGPD3q9dxRwjPPM9GHdzzzJNPQW1FRGL90HaGQA/0, createdBy=05f12229743, createdName=废伟伟, createdTime=Fri May 14 22:54:07 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970884, encodeId=4a529e088448, content=朋友们，5月21号投出去，到现在还是initial validation 还没有分配编辑，要等多久啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b13f1619698, createdName=ZF2012ZF, createdTime=Fri Jun 04 15:07:01 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180155, encodeId=796011801550d, content=果断撤稿，不能投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Mon Jan 03 21:04:03 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581287, encodeId=2d8a58128e95, content=审稿速度:1.0 经验分享：这杂志速度惊人，投稿后一个月修回，审稿人一个小修，一个moderate修。修回后一周接收。全程两个月。光速好评。而且修回界面，是审稿人与作者的对话模式。非常新颖。接收以后才能看到审稿人的名字。投稿的时候会建议你从编辑库里选择编辑。投稿，修稿模式非常干净，简洁，新颖。最关键是快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f4d1979640, createdName=毛教授, createdTime=Wed Dec 11 00:00:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958196, encodeId=a29c9581965c, content=Independent review 2个月！！！！发邮件催了一下，石沉大海什么回复都没有！我是真的服了！！！这期刊真乃神刊也！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1f55081875, createdName=飞翔的阿吉, createdTime=Mon Apr 19 02:48:29 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898988, encodeId=9d7e898988be, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：9.18 由Frontiers in immunology转投至此 10.19 interactive reriew activated 11.6 resubmitted manuscript 11.11 review finalized<a href='/topic/show?id=f9e2832202f' target=_blank style='color:#2F92EE;'>#胃癌#</a> 11.12 final validation 11.13 accepted for publication 审稿人和编辑蛮负责的，有误和不足之处指点得比较细致，工作效率还蛮高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=6, topicName=null, topicId=null, topicList=[TopicDto(id=83220, encryptionId=f9e2832202f, topicName=胃癌)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2d15412768, createdName=丐帮首席Scientist, createdTime=Fri Nov 13 18:20:02 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805182, encodeId=31688051823b, content=请问一下，Editorial Assignment一个月多了，一直都在这个状态，是没有找到审稿人吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vp81ML0pFfyNwFwGEx9Pw33qtqCn5M04bic15eUEPrwph5jOCicrTRKvKUX6JT7fiawspFQ85y9bCFrahoBiagwsSw/132, createdBy=faf35236748, createdName=治愈., createdTime=Thu Jul 30 12:05:59 CST 2020, time=2020-07-30, status=1, ipAttribution=)]

2021-06-04 ZF2012ZF

朋友们，5月21号投出去，到现在还是initial validation 还没有分配编辑，要等多久啊😭

47 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=895604, encodeId=5b52895604e7, content=审稿速度:2.0 | 投稿命中率:100.0 | 版面费用:2750.0 偏重的研究方向：肿瘤;表观遗传 经验分享：20200324 提交 20200324 Initial Validation 20200325 Editorial Assignment 20200404 Independent Review 20200421 Interactive Review 20200502 回复问题，re-submit 20200507 Review Finalized 20200507 Final Validation 20200508 Final Decision 20200512 打钱 20200526-28 proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/17/4853d202ade50d0bdf35e3b421ad93b5.jpg, createdBy=05211666592, createdName=杨小雅, createdTime=Fri Oct 30 09:39:51 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899607, encodeId=acb089960eba, content=投稿半个月了，还是editor assignment, 怎么还不送审，大家知道啥情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=The chief editor of bbrc, createdTime=Mon Nov 16 13:23:44 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967629, encodeId=8f9c96e6294d, content=请问纯生信，没有基础实验验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 21 23:34:12 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965712, encodeId=eae6965e12b4, content=生信文章为啥突然问我要原始数据，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/icsxtd8pwFpo8Pxq0EZRrQbNZVO7LicJTJ43Pg6pGhE4WawzWaGPD3q9dxRwjPPM9GHdzzzJNPQW1FRGL90HaGQA/0, createdBy=05f12229743, createdName=废伟伟, createdTime=Fri May 14 22:54:07 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970884, encodeId=4a529e088448, content=朋友们，5月21号投出去，到现在还是initial validation 还没有分配编辑，要等多久啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b13f1619698, createdName=ZF2012ZF, createdTime=Fri Jun 04 15:07:01 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180155, encodeId=796011801550d, content=果断撤稿，不能投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Mon Jan 03 21:04:03 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581287, encodeId=2d8a58128e95, content=审稿速度:1.0 经验分享：这杂志速度惊人，投稿后一个月修回，审稿人一个小修，一个moderate修。修回后一周接收。全程两个月。光速好评。而且修回界面，是审稿人与作者的对话模式。非常新颖。接收以后才能看到审稿人的名字。投稿的时候会建议你从编辑库里选择编辑。投稿，修稿模式非常干净，简洁，新颖。最关键是快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f4d1979640, createdName=毛教授, createdTime=Wed Dec 11 00:00:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958196, encodeId=a29c9581965c, content=Independent review 2个月！！！！发邮件催了一下，石沉大海什么回复都没有！我是真的服了！！！这期刊真乃神刊也！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1f55081875, createdName=飞翔的阿吉, createdTime=Mon Apr 19 02:48:29 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898988, encodeId=9d7e898988be, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：9.18 由Frontiers in immunology转投至此 10.19 interactive reriew activated 11.6 resubmitted manuscript 11.11 review finalized<a href='/topic/show?id=f9e2832202f' target=_blank style='color:#2F92EE;'>#胃癌#</a> 11.12 final validation 11.13 accepted for publication 审稿人和编辑蛮负责的，有误和不足之处指点得比较细致，工作效率还蛮高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=6, topicName=null, topicId=null, topicList=[TopicDto(id=83220, encryptionId=f9e2832202f, topicName=胃癌)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2d15412768, createdName=丐帮首席Scientist, createdTime=Fri Nov 13 18:20:02 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805182, encodeId=31688051823b, content=请问一下，Editorial Assignment一个月多了，一直都在这个状态，是没有找到审稿人吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vp81ML0pFfyNwFwGEx9Pw33qtqCn5M04bic15eUEPrwph5jOCicrTRKvKUX6JT7fiawspFQ85y9bCFrahoBiagwsSw/132, createdBy=faf35236748, createdName=治愈., createdTime=Thu Jul 30 12:05:59 CST 2020, time=2020-07-30, status=1, ipAttribution=)]

2022-01-03 鸭嘴兽花

果断撤稿，不能投了

48 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=895604, encodeId=5b52895604e7, content=审稿速度:2.0 | 投稿命中率:100.0 | 版面费用:2750.0 偏重的研究方向：肿瘤;表观遗传 经验分享：20200324 提交 20200324 Initial Validation 20200325 Editorial Assignment 20200404 Independent Review 20200421 Interactive Review 20200502 回复问题，re-submit 20200507 Review Finalized 20200507 Final Validation 20200508 Final Decision 20200512 打钱 20200526-28 proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/17/4853d202ade50d0bdf35e3b421ad93b5.jpg, createdBy=05211666592, createdName=杨小雅, createdTime=Fri Oct 30 09:39:51 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899607, encodeId=acb089960eba, content=投稿半个月了，还是editor assignment, 怎么还不送审，大家知道啥情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=The chief editor of bbrc, createdTime=Mon Nov 16 13:23:44 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967629, encodeId=8f9c96e6294d, content=请问纯生信，没有基础实验验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 21 23:34:12 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965712, encodeId=eae6965e12b4, content=生信文章为啥突然问我要原始数据，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/icsxtd8pwFpo8Pxq0EZRrQbNZVO7LicJTJ43Pg6pGhE4WawzWaGPD3q9dxRwjPPM9GHdzzzJNPQW1FRGL90HaGQA/0, createdBy=05f12229743, createdName=废伟伟, createdTime=Fri May 14 22:54:07 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970884, encodeId=4a529e088448, content=朋友们，5月21号投出去，到现在还是initial validation 还没有分配编辑，要等多久啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b13f1619698, createdName=ZF2012ZF, createdTime=Fri Jun 04 15:07:01 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180155, encodeId=796011801550d, content=果断撤稿，不能投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Mon Jan 03 21:04:03 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581287, encodeId=2d8a58128e95, content=审稿速度:1.0 经验分享：这杂志速度惊人，投稿后一个月修回，审稿人一个小修，一个moderate修。修回后一周接收。全程两个月。光速好评。而且修回界面，是审稿人与作者的对话模式。非常新颖。接收以后才能看到审稿人的名字。投稿的时候会建议你从编辑库里选择编辑。投稿，修稿模式非常干净，简洁，新颖。最关键是快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f4d1979640, createdName=毛教授, createdTime=Wed Dec 11 00:00:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958196, encodeId=a29c9581965c, content=Independent review 2个月！！！！发邮件催了一下，石沉大海什么回复都没有！我是真的服了！！！这期刊真乃神刊也！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1f55081875, createdName=飞翔的阿吉, createdTime=Mon Apr 19 02:48:29 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898988, encodeId=9d7e898988be, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：9.18 由Frontiers in immunology转投至此 10.19 interactive reriew activated 11.6 resubmitted manuscript 11.11 review finalized<a href='/topic/show?id=f9e2832202f' target=_blank style='color:#2F92EE;'>#胃癌#</a> 11.12 final validation 11.13 accepted for publication 审稿人和编辑蛮负责的，有误和不足之处指点得比较细致，工作效率还蛮高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=6, topicName=null, topicId=null, topicList=[TopicDto(id=83220, encryptionId=f9e2832202f, topicName=胃癌)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2d15412768, createdName=丐帮首席Scientist, createdTime=Fri Nov 13 18:20:02 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805182, encodeId=31688051823b, content=请问一下，Editorial Assignment一个月多了，一直都在这个状态，是没有找到审稿人吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vp81ML0pFfyNwFwGEx9Pw33qtqCn5M04bic15eUEPrwph5jOCicrTRKvKUX6JT7fiawspFQ85y9bCFrahoBiagwsSw/132, createdBy=faf35236748, createdName=治愈., createdTime=Thu Jul 30 12:05:59 CST 2020, time=2020-07-30, status=1, ipAttribution=)]

2019-12-11 毛教授

审稿速度:1.0
经验分享：这杂志速度惊人，投稿后一个月修回，审稿人一个小修，一个moderate修。修回后一周接收。全程两个月。光速好评。而且修回界面，是审稿人与作者的对话模式。非常新颖。接收以后才能看到审稿人的名字。投稿的时候会建议你从编辑库里选择编辑。投稿，修稿模式非常干净，简洁，新颖。最关键是快。

116 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=895604, encodeId=5b52895604e7, content=审稿速度:2.0 | 投稿命中率:100.0 | 版面费用:2750.0 偏重的研究方向：肿瘤;表观遗传 经验分享：20200324 提交 20200324 Initial Validation 20200325 Editorial Assignment 20200404 Independent Review 20200421 Interactive Review 20200502 回复问题，re-submit 20200507 Review Finalized 20200507 Final Validation 20200508 Final Decision 20200512 打钱 20200526-28 proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/17/4853d202ade50d0bdf35e3b421ad93b5.jpg, createdBy=05211666592, createdName=杨小雅, createdTime=Fri Oct 30 09:39:51 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899607, encodeId=acb089960eba, content=投稿半个月了，还是editor assignment, 怎么还不送审，大家知道啥情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=The chief editor of bbrc, createdTime=Mon Nov 16 13:23:44 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967629, encodeId=8f9c96e6294d, content=请问纯生信，没有基础实验验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 21 23:34:12 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965712, encodeId=eae6965e12b4, content=生信文章为啥突然问我要原始数据，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/icsxtd8pwFpo8Pxq0EZRrQbNZVO7LicJTJ43Pg6pGhE4WawzWaGPD3q9dxRwjPPM9GHdzzzJNPQW1FRGL90HaGQA/0, createdBy=05f12229743, createdName=废伟伟, createdTime=Fri May 14 22:54:07 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970884, encodeId=4a529e088448, content=朋友们，5月21号投出去，到现在还是initial validation 还没有分配编辑，要等多久啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b13f1619698, createdName=ZF2012ZF, createdTime=Fri Jun 04 15:07:01 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180155, encodeId=796011801550d, content=果断撤稿，不能投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Mon Jan 03 21:04:03 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581287, encodeId=2d8a58128e95, content=审稿速度:1.0 经验分享：这杂志速度惊人，投稿后一个月修回，审稿人一个小修，一个moderate修。修回后一周接收。全程两个月。光速好评。而且修回界面，是审稿人与作者的对话模式。非常新颖。接收以后才能看到审稿人的名字。投稿的时候会建议你从编辑库里选择编辑。投稿，修稿模式非常干净，简洁，新颖。最关键是快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f4d1979640, createdName=毛教授, createdTime=Wed Dec 11 00:00:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958196, encodeId=a29c9581965c, content=Independent review 2个月！！！！发邮件催了一下，石沉大海什么回复都没有！我是真的服了！！！这期刊真乃神刊也！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1f55081875, createdName=飞翔的阿吉, createdTime=Mon Apr 19 02:48:29 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898988, encodeId=9d7e898988be, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：9.18 由Frontiers in immunology转投至此 10.19 interactive reriew activated 11.6 resubmitted manuscript 11.11 review finalized<a href='/topic/show?id=f9e2832202f' target=_blank style='color:#2F92EE;'>#胃癌#</a> 11.12 final validation 11.13 accepted for publication 审稿人和编辑蛮负责的，有误和不足之处指点得比较细致，工作效率还蛮高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=6, topicName=null, topicId=null, topicList=[TopicDto(id=83220, encryptionId=f9e2832202f, topicName=胃癌)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2d15412768, createdName=丐帮首席Scientist, createdTime=Fri Nov 13 18:20:02 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805182, encodeId=31688051823b, content=请问一下，Editorial Assignment一个月多了，一直都在这个状态，是没有找到审稿人吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vp81ML0pFfyNwFwGEx9Pw33qtqCn5M04bic15eUEPrwph5jOCicrTRKvKUX6JT7fiawspFQ85y9bCFrahoBiagwsSw/132, createdBy=faf35236748, createdName=治愈., createdTime=Thu Jul 30 12:05:59 CST 2020, time=2020-07-30, status=1, ipAttribution=)]

2021-04-19 飞翔的阿吉

Independent review 2个月！！！！发邮件催了一下，石沉大海什么回复都没有！我是真的服了！！！这期刊真乃神刊也！！

61 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=895604, encodeId=5b52895604e7, content=审稿速度:2.0 | 投稿命中率:100.0 | 版面费用:2750.0 偏重的研究方向：肿瘤;表观遗传 经验分享：20200324 提交 20200324 Initial Validation 20200325 Editorial Assignment 20200404 Independent Review 20200421 Interactive Review 20200502 回复问题，re-submit 20200507 Review Finalized 20200507 Final Validation 20200508 Final Decision 20200512 打钱 20200526-28 proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/17/4853d202ade50d0bdf35e3b421ad93b5.jpg, createdBy=05211666592, createdName=杨小雅, createdTime=Fri Oct 30 09:39:51 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899607, encodeId=acb089960eba, content=投稿半个月了，还是editor assignment, 怎么还不送审，大家知道啥情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=The chief editor of bbrc, createdTime=Mon Nov 16 13:23:44 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967629, encodeId=8f9c96e6294d, content=请问纯生信，没有基础实验验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 21 23:34:12 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965712, encodeId=eae6965e12b4, content=生信文章为啥突然问我要原始数据，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/icsxtd8pwFpo8Pxq0EZRrQbNZVO7LicJTJ43Pg6pGhE4WawzWaGPD3q9dxRwjPPM9GHdzzzJNPQW1FRGL90HaGQA/0, createdBy=05f12229743, createdName=废伟伟, createdTime=Fri May 14 22:54:07 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970884, encodeId=4a529e088448, content=朋友们，5月21号投出去，到现在还是initial validation 还没有分配编辑，要等多久啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b13f1619698, createdName=ZF2012ZF, createdTime=Fri Jun 04 15:07:01 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180155, encodeId=796011801550d, content=果断撤稿，不能投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Mon Jan 03 21:04:03 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581287, encodeId=2d8a58128e95, content=审稿速度:1.0 经验分享：这杂志速度惊人，投稿后一个月修回，审稿人一个小修，一个moderate修。修回后一周接收。全程两个月。光速好评。而且修回界面，是审稿人与作者的对话模式。非常新颖。接收以后才能看到审稿人的名字。投稿的时候会建议你从编辑库里选择编辑。投稿，修稿模式非常干净，简洁，新颖。最关键是快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f4d1979640, createdName=毛教授, createdTime=Wed Dec 11 00:00:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958196, encodeId=a29c9581965c, content=Independent review 2个月！！！！发邮件催了一下，石沉大海什么回复都没有！我是真的服了！！！这期刊真乃神刊也！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1f55081875, createdName=飞翔的阿吉, createdTime=Mon Apr 19 02:48:29 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898988, encodeId=9d7e898988be, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：9.18 由Frontiers in immunology转投至此 10.19 interactive reriew activated 11.6 resubmitted manuscript 11.11 review finalized<a href='/topic/show?id=f9e2832202f' target=_blank style='color:#2F92EE;'>#胃癌#</a> 11.12 final validation 11.13 accepted for publication 审稿人和编辑蛮负责的，有误和不足之处指点得比较细致，工作效率还蛮高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=6, topicName=null, topicId=null, topicList=[TopicDto(id=83220, encryptionId=f9e2832202f, topicName=胃癌)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2d15412768, createdName=丐帮首席Scientist, createdTime=Fri Nov 13 18:20:02 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805182, encodeId=31688051823b, content=请问一下，Editorial Assignment一个月多了，一直都在这个状态，是没有找到审稿人吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vp81ML0pFfyNwFwGEx9Pw33qtqCn5M04bic15eUEPrwph5jOCicrTRKvKUX6JT7fiawspFQ85y9bCFrahoBiagwsSw/132, createdBy=faf35236748, createdName=治愈., createdTime=Thu Jul 30 12:05:59 CST 2020, time=2020-07-30, status=1, ipAttribution=)]

2020-11-13 丐帮首席Scientist

审稿速度:1.0 | 投稿命中率:75.0
经验分享：9.18 由Frontiers in immunology转投至此 10.19 interactive reriew activated 11.6 resubmitted manuscript 11.11 review finalized#胃癌# 11.12 final validation 11.13 accepted for publication 审稿人和编辑蛮负责的，有误和不足之处指点得比较细致，工作效率还蛮高。

210 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=895604, encodeId=5b52895604e7, content=审稿速度:2.0 | 投稿命中率:100.0 | 版面费用:2750.0 偏重的研究方向：肿瘤;表观遗传 经验分享：20200324 提交 20200324 Initial Validation 20200325 Editorial Assignment 20200404 Independent Review 20200421 Interactive Review 20200502 回复问题，re-submit 20200507 Review Finalized 20200507 Final Validation 20200508 Final Decision 20200512 打钱 20200526-28 proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/17/4853d202ade50d0bdf35e3b421ad93b5.jpg, createdBy=05211666592, createdName=杨小雅, createdTime=Fri Oct 30 09:39:51 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899607, encodeId=acb089960eba, content=投稿半个月了，还是editor assignment, 怎么还不送审，大家知道啥情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=The chief editor of bbrc, createdTime=Mon Nov 16 13:23:44 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967629, encodeId=8f9c96e6294d, content=请问纯生信，没有基础实验验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 21 23:34:12 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965712, encodeId=eae6965e12b4, content=生信文章为啥突然问我要原始数据，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/icsxtd8pwFpo8Pxq0EZRrQbNZVO7LicJTJ43Pg6pGhE4WawzWaGPD3q9dxRwjPPM9GHdzzzJNPQW1FRGL90HaGQA/0, createdBy=05f12229743, createdName=废伟伟, createdTime=Fri May 14 22:54:07 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970884, encodeId=4a529e088448, content=朋友们，5月21号投出去，到现在还是initial validation 还没有分配编辑，要等多久啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b13f1619698, createdName=ZF2012ZF, createdTime=Fri Jun 04 15:07:01 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180155, encodeId=796011801550d, content=果断撤稿，不能投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=574f5417698, createdName=鸭嘴兽花, createdTime=Mon Jan 03 21:04:03 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581287, encodeId=2d8a58128e95, content=审稿速度:1.0 经验分享：这杂志速度惊人，投稿后一个月修回，审稿人一个小修，一个moderate修。修回后一周接收。全程两个月。光速好评。而且修回界面，是审稿人与作者的对话模式。非常新颖。接收以后才能看到审稿人的名字。投稿的时候会建议你从编辑库里选择编辑。投稿，修稿模式非常干净，简洁，新颖。最关键是快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f4d1979640, createdName=毛教授, createdTime=Wed Dec 11 00:00:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958196, encodeId=a29c9581965c, content=Independent review 2个月！！！！发邮件催了一下，石沉大海什么回复都没有！我是真的服了！！！这期刊真乃神刊也！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1f55081875, createdName=飞翔的阿吉, createdTime=Mon Apr 19 02:48:29 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898988, encodeId=9d7e898988be, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：9.18 由Frontiers in immunology转投至此 10.19 interactive reriew activated 11.6 resubmitted manuscript 11.11 review finalized<a href='/topic/show?id=f9e2832202f' target=_blank style='color:#2F92EE;'>#胃癌#</a> 11.12 final validation 11.13 accepted for publication 审稿人和编辑蛮负责的，有误和不足之处指点得比较细致，工作效率还蛮高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=6, topicName=null, topicId=null, topicList=[TopicDto(id=83220, encryptionId=f9e2832202f, topicName=胃癌)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2d15412768, createdName=丐帮首席Scientist, createdTime=Fri Nov 13 18:20:02 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805182, encodeId=31688051823b, content=请问一下，Editorial Assignment一个月多了，一直都在这个状态，是没有找到审稿人吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/vp81ML0pFfyNwFwGEx9Pw33qtqCn5M04bic15eUEPrwph5jOCicrTRKvKUX6JT7fiawspFQ85y9bCFrahoBiagwsSw/132, createdBy=faf35236748, createdName=治愈., createdTime=Thu Jul 30 12:05:59 CST 2020, time=2020-07-30, status=1, ipAttribution=)]

2020-07-30 治愈.

请问一下，Editorial Assignment一个月多了，一直都在这个状态，是没有找到审稿人吗？

93 6

展开6条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务